Global Targeted Oncology Therapeutics Market Report 2020 - Shares of Approved Therapeutics, Market Leaders by Indication & Product

News provided by

Mar 13, 2020, 12:00 ET

DUBLIN, March 13, 2020 /PRNewswire/ -- The "Targeted Oncology Therapeutics: Therapeutics, Markets, Players and Forecasts" report has been added to ResearchAndMarkets.com's offering.

A number of factors are changing the way market participants view the cancer therapeutics market. These factors are evident in the disease targets and drug classes that comprise a significant number of recent trials.

After decades of disappointment and missed financial objectives, the genetic underpinnings of disease are converging with improved computer-assisted pharmacological decision making. Market sector participants now find themselves pursuing realistic therapeutic strategies that have the potential to fulfill product strategies in both scientific and human terms.

What You Will Learn

What is the market share of approved therapeutics?
What is the global supply picture for targeted therapeutics?
Who are the market leaders, by Indication? by Product?
What is the therapeutic coverage across all oncology indications? What are the product opportunities?
What are the established products in this space? by target, indication, API class, revenue?
What is the competitive picture for the major Oncology market segments?

Drug treatment resources
Competitive therapy map
Clinical trial activity

Who are the leading competitors in the field of next-generation therapeutics?

Key Topics Covered

Executive Summary
The Recombinant Drug Ecosystem
Targeted Oncology Therapeutics Market Leaders
Oncology Biologics - Competitive Considerations
Approved Drugs for targeted Oncology Therapeutics
FDA-approved Drugs
EMA-approved Drugs
Biosimilars of Trastuzumab
EMA Approved Biosimilars
The Impact of Litigation on Biosimilar Product Launches
Target Oncology Therapeutics - Market Segments
Breast Cancers
Colorectal Cancers
Hematology Cancers
Lung Cancers
Melanomas
Metastatic Gastric Cancers
Neurological Cancers
Renal Cell Carcinomas
Urothelial Cancers
Supplier Competitive Assessments

Charts, Tables, Graphs, and Visualizations

Approved mAbs - Market Share by Product Activity

Global Supplier Activity Map
Targeted Oncology Market Leaders (Indications, Products)
FDA/EMA Approved Product Market Coverage by Supplier

Established Products (Baseline & Commercialization Summaries)

Adcetris (Detailed Profiles, Indications, Dosage Form, Historical Revenue, Revenue Forecast)
Avastin
Blincyto
Cyramza
Adcetris
Darzalex
Empliciti
Erbitux
Gazyva
Herceptin
Imfinzi
Keytruda
Opdivo
Perjeta
Rituxan
Tecentriq
Vectibix
Yervoy
Zevalin

Emerging Products

Arzerra (Detailed Profiles, Indications, Supply Chain)
Bavencio
Besponsa
Enhertu
Herzuma
Kadcyla
Kanjinti
Lartruvo
Libtayo
Lumoxiti
Mvasi
Ogivri
Omtruzant
Padcev
Polivy
Portrazza
Poteligeo
Ruxience
Truxima
Unituxin
Zirabev
EMA Approved Biosimilars, All
EMA, Approved Biosimilars for Oncology Incications
Biosimilars, Patent Litigation Impact Map

Targeted Oncology Market Assessments

Breast Cancer - Drug Treatment Resource Map, by Type
Breast Cancer - Competitive Therapy Map, Total Revenue by Year
Breast Cancer - Clinical Trial Activity, Sponsor/Collaborator
Breast Cancer - Clinical Trial Activity, First-listed Interventional Therapeutic
Breast Cancer - Clinical Trial Activity by Trial Phase
Colorectal Cancer
Hematology Cancers
Lung Cancers
Melanomas
Metastatic Gastric Cancers
Neurological Cancers
Renal Cell Carcinomas
Urothelial Cancers

Supplier Competitive Assessments

For more information about this report visit https://www.researchandmarkets.com/r/2yln5k

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets